Pennsylvania · 88188

Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Pennsylvania

Pennsylvania Medicare Avg
$49.55
2% above national avg
National Medicare Avg
$48.39
All states combined
Billed Charge (PA)
$371.14
What providers submit
Est. Commercial (PA)
$138.45
National avg: $138.37
Est. Cash / Self-Pay (PA)
$149.26
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.6K
Services in PA
81
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Pennsylvania

Provider Medicare Services
Frank, Dale MD $50.56 458
Caponetti, Gabriel MD $49.81 344
Pozdnyakova, Olga MD $52.10 117
Zemba-Palko, Vlasta M.D. $51.45 48
Zhou, Jing MD $51.45 14
Health Network Laboratories, Llc $47.21 14
Carlsen, Eric MD, PHD $36.04 13

Pennsylvania Pricing in Context

In Pennsylvania, CPT code 88188 (Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers) carries an average Medicare payment of $49.55 — 2% above the national benchmark of $48.39. 81 providers across the state submitted claims for this procedure in 2023, performing 2.6K total services. Individual payments in PA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Pennsylvania is $371.14, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Pennsylvania sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Pennsylvania lands near $138.45, with self-pay cash prices typically around $149.26. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost in Pennsylvania?

The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Pennsylvania is $49.55, which is 2% above the national average of $48.39. Providers in PA typically bill $371.14 for this procedure.

What does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost with insurance in Pennsylvania?

With commercial insurance in Pennsylvania, Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs an estimated $138.45. Without insurance, the estimated cash price is $149.26. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in Pennsylvania?

81 providers in Pennsylvania billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in 2023, performing 2.6K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cheaper in Pennsylvania than the national average?

No — Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs 2% above the national average in Pennsylvania. The state average Medicare payment is $49.55 compared to $48.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial